SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-15-000789
Filing Date
2015-07-28
Accepted
2015-07-28 20:59:47
Documents
1
Period of Report
2015-07-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4072515bacha_delmarpharma.html 4  
1 OWNERSHIP DOCUMENT f4072515bacha_delmarpharma.xml 4 5236
  Complete submission text file 0001013762-15-000789.txt   6692
Mailing Address SUITE 3 1545 WEST 14TH AVENUE VANCOUVER A1 V6J 2J1
Business Address
BACHA JEFFREY (Reporting) CIK: 0001432149 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54801 | Film No.: 151010949

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations